Expression levels of NLRP3 and NLRP1, as well as cleavage products of caspase‐1, IL‐1β, and IL‐18, were shown to be elevated in postmortem brain tissue of stroke patients (Fann et al, 2013). The gene discussed is NLRP3; the disease is Stroke.